506687

Transpek Inds. financials

Market cap
₹746 Cr
Sector
Chemicals
Calls analysed
2
Latest concall · Q1 FY27 · call held 20 Aug 2026

Transpek Inds. Q1 FY27

Revenue ₹155.1 cr −7%EBITDA ₹24.1 cr −32%EBITDA Margin 15.6% Profit After Tax ₹8.9 cr

What went well

  • Net debt-free company with strong balance sheet and healthy cash flows as of June 2026.
  • New acid chloride products expected to grow significantly from INR4 crores (FY26) to INR15 crores (FY27).
  • Strategic shift towards aggressive growth, aiming to double business size in next 5 years.

What to watch

  • Q1 FY27 total revenue declined by 6.5% YoY to INR155.1 crores.
  • Q1 FY27 EBITDA decreased by 32.4% YoY to INR24.1 crores, with EBITDA margin at 15.6%.
Read the full call →

What Transpek Inds. does

Transpek Industry Limited manufactures chlorinated and sulphur-based specialty chemicals, including Thionyl Chloride and a range of acid chlorides and alkyl chlorides, used as intermediates for pharmaceuticals, agrochemicals, dyes, polymers, cosmetics and surfactants. It operates multipurpose, multiproduct manufacturing plants at Ekalbara near Vadodara, Gujarat, supported by an in-house R&D facility for developing new chlorination-based chemistries. The company exports to customers across roughly 16 countries including the US, Europe and Japan, moving bulk chemicals through its own managed fleet of ISO tank containers. It is part of the Excel Industries group of companies.

Segments

  • Polymers
  • Pharma
  • Specialty Chemicals
  • Agrochemicals
  • Cosmetics
  • Dyes
  • Surfactants
Installed production capacity
66,000 MTPA
Manufacturing facility
Multipurpose, multiproduct plants at Ekalbara (Vadodara, Gujarat), spread over 100 acres
Export footprint
Presence across 16 countries
Capacity utilization
~65% (Q3 FY25)
ISO tank logistics fleet
600+ ISO tanks with own repair and cleaning stations
Operating history
50+ years of experience in chlorine and sulphur chemistry
Founded 1965Headquarters Vadodara, Gujarat, India Company website

Guidance record · Q1 FY27

what the last two calls moved 15 tracked 0 delivered 5 missed 10 open
  • New Products EBITDA Margins went quiet said Q3 FY25 Promised: 20% Q1 FY27: No specific update on new product margins. Management provided overall company EBITDA margin guidance of 15-20%.
  • New Products Revenue (Non-Acid Chloride) delayed said Q3 FY25 Promised: ₹150-200 crores annually within 2 years Q1 FY27: Timelines for new polymer products (potential ₹100cr) have been pushed out, with one starting revenue in Q4 FY27 and another in FY28, missing the original 2-year deadline (end of Q3 FY27).
  • DuPont Contract Volume on track said Q3 FY25 Promised: Sustain current supply volumes until current contract ends Q1 FY27: Management confirmed the contract, now with Arclin, continues without disruption. Renewal discussions are set to begin in late 2026.

All 15 tracked — every revision, and every one management stopped mentioning.

Open the guidance ledger

Quarterly results

Q1 FY27: revenue down 2.1%, net profit down 42.7% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue163 170 165 154 160 −1%158 −7%148 −10%151 −2%
EBITDA23 24 32 24 27 +18%25 +4%18 −45%20 −16%
Net profit10 11 19 16 13 +32%11 +2%7 −66%9 −43%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −2.8% 1Y

₹1.0k₹1.2k₹1.4kSept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Q1 FY27 — 20 Aug 2026

1Y: ₹1,337.95 on 10 Sept 2025 → ₹1,300. High ₹1,478.4 (10 Oct 2025), low ₹876.3 (30 Mar 2026).

How the price took the results

close before → close after

Q1 FY27
+2.8%
20 Aug

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Financials, as filed

Revenue fell 9.1% a year over 3 years, FY23 to FY26. Operating margin narrowed to 15.0%.

Year endingFY23FY24FY25FY26
Revenue₹826 Cr₹580 Cr₹650 Cr₹621 Cr
Operating profit₹147 Cr₹82 Cr₹95 Cr₹93 Cr
Operating margin17.8%14.2%14.6%15.0%
Interest₹20 Cr₹14 Cr₹12 Cr₹8 Cr
Depreciation₹32 Cr₹38 Cr₹50 Cr₹49 Cr
Net profit₹83 Cr₹39 Cr₹49 Cr₹46 Cr
Net margin10.1%6.7%7.5%7.3%
Cash from operations₹111 Cr₹98 Cr₹135 Cr₹78 Cr
Free cash flow₹66 Cr₹60 Cr₹116 Cr₹41 Cr
ROCE20.0%9.0%10.0%8.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr
Reserves₹374 Cr₹479 Cr₹581 Cr₹668 Cr₹762 Cr₹762 Cr
Borrowings₹111 Cr₹137 Cr₹145 Cr₹123 Cr₹41 Cr₹74 Cr
Other liabilities₹108 Cr₹143 Cr₹155 Cr₹169 Cr₹191 Cr₹166 Cr
Total liabilities₹599 Cr₹764 Cr₹887 Cr₹966 Cr₹1.0k Cr₹1.0k Cr
Fixed assets₹287 Cr₹295 Cr₹365 Cr₹397 Cr₹342 Cr₹343 Cr
Capital work in progress₹14 Cr₹16 Cr₹24 Cr₹6 Cr₹13 Cr₹5 Cr
Investments₹142 Cr₹196 Cr₹238 Cr₹321 Cr₹335 Cr₹317 Cr
Other assets₹156 Cr₹258 Cr₹260 Cr₹242 Cr₹310 Cr₹344 Cr
Total assets₹599 Cr₹764 Cr₹887 Cr₹966 Cr₹1.0k Cr₹1.0k Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, the public added +1.00 pp while DIIs trimmed −0.78 pp.

Promoters
57.3%
FIIs
0.0%
DIIs
1.1%
Public
41.6%

Since Jun 2025

  • Public +1.00 pp
  • DIIs −0.78 pp
  • Promoters −0.19 pp

How it drifted, 12 quarters

Over this window the public went from 38.9% to 41.6% — +2.8 pp.

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 57.5%, FIIs 1.9%, DIIs 1.8%, Public 38.9%.Dec '23: Promoters 57.5%, FIIs 0.9%, DIIs 1.8%, Public 39.8%.Mar '24: Promoters 57.5%, FIIs 0.1%, DIIs 1.8%, Public 40.7%.Jun '24: Promoters 57.5%, FIIs 0.1%, DIIs 1.8%, Public 40.7%.Sep '24: Promoters 57.5%, FIIs 0.1%, DIIs 1.9%, Public 40.6%.Dec '24: Promoters 57.5%, FIIs 0.0%, DIIs 1.9%, Public 40.6%.Mar '25: Promoters 57.5%, FIIs 0.0%, DIIs 1.9%, Public 40.6%.Jun '25: Promoters 57.5%, FIIs 0.0%, DIIs 1.8%, Public 40.6%.Sep '25: Promoters 57.5%, FIIs 0.0%, DIIs 1.6%, Public 40.9%.Dec '25: Promoters 57.5%, FIIs 0.0%, DIIs 1.6%, Public 40.9%.Mar '26: Promoters 57.5%, FIIs 0.0%, DIIs 1.6%, Public 40.9%.Jun '26: Promoters 57.3%, FIIs 0.0%, DIIs 1.1%, Public 41.6%.

Who was buying across the market this quarter →

Who is on the register

Named in the Jun 2026 filing

Every holder of Transpek Inds. above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Anshul Specialty Molecules Private Limited 24.64%unchanged
Kamaljyot Investments Limited 12.58%unchanged
Ashwin Champraj Shroff 10.75%unchanged
Dipkanti Investments And Financing Private Limited 3.65%unchanged
Mukul Mahavir Agrawal 2.12%unchanged
Finquest Securities Private Limited - Proprietary Account 1.80%unchanged
Madison Investments Private Limited 1.31%unchanged
Gaurav Naresh Lodha 1.21%unchanged
Minal Bharat Patel 1.10%unchanged
Unifi Financial Pvt Ltd 1.06%unchanged
Preeti Dipesh Shroff 0.91%unchanged
Upl Limited 0.74%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

What the price assumes

Growth trap

To justify its price of ₹1300, this stock must grow earnings at 17% every year for 7 years. Our analysis caps realistic growth at ~-18%. At that growth it is worth ₹196 — downside of 85%.

Growth the price implies
16.6% a year
for 7 years, fading to 4%
It has actually compounded at
-18.2% a year
net profit, FY23–FY26 · EPS -18.2%
The gap
0.3 pp
-85% downside if it only repeats history
Price today ₹1,300 Value at the reference growth ₹195.89

Change the assumptions yourself →

All earnings calls (2)

Read the Q1 FY27 call →

Learn to analyse Transpek Inds.

Guides on how to read this kind of business and the numbers that matter.